Business · 03/09/2015Updated: 10/17/2026 · 1 min read
FDA Renewal of Nonprescription Drugs Advisory Committee Charter
Summary
The Food and Drug Administration (FDA) is renewing the Nonprescription Drugs Advisory Committee for an additional 2 years, with the new charter set to expire on August 27, 2015. The Commissioner of Food and Drugs has made this decision in the public interest.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →